查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1969083

腦健康設備市場：全球預測（2026-2032 年），按設備類型、技術、年齡層、應用、最終用戶和分銷管道分類

Brain Health Device Market by Device Type, Technology, Age Group, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，腦健康設備市場價值將達到 85.9 億美元，到 2026 年將成長至 96.2 億美元，到 2032 年將達到 192.5 億美元，複合年成長率為 12.22%。

主要市場統計數據
基準年 2025 85.9億美元
預計年份：2026年 96.2億美元
預測年份 2032 192.5億美元
複合年成長率 (%) 12.22%

本文探討了腦部健康設備領域不斷演變的格局，其中臨床嚴謹性、消費者期望和技術融合決定了策略挑戰。

腦健康設備領域融合了臨床神經科學、消費技術和數位治療方法，形成了一個獨特的類別，整合了生理感測、神經調控和軟體驅動的認知評估。非侵入性刺激技術的進步、精密的神經回饋系統以及日益先進的穿戴式設備，正在拓展臨床路徑和日常健康選擇。在這種模式下，設備生態系統不再只是一系列獨立的產品線，而是一套相互連結的工具網路，為尋求提升認知功能的患者、臨床醫生、運動員和消費者創造醫療、行為和體驗價值。

變革性的技術、監管和行為變化正在推動腦健康設備在臨床和商業性應用方面取得新的突破。

腦健康設備領域正受到三大因素的共同影響而重塑：科技的快速成熟、監管要求的不斷演變以及臨床和消費領域使用者行為的改變。在技​​術層面，感測器精確度的提升、訊號處理技術的進步以及封閉回路型神經調控技術的進步，在擴大臨床意義終點範圍的同時，也減輕了使用者的負擔。這些進步正促使設備從輔助研究工具轉變為整合式醫療服務推動者和具有更清晰療效路徑的消費者健康產品。

本研究評估了美國關稅趨勢在 2025 年將如何造成供應鏈、定價和策略轉變，從而對設備商業化和採購產生重大影響。

美國在2025年實施的關稅將對腦健康設備公司產生複雜的營運和策略影響，其影響遠不止於直接的成本壓力。特別是，關稅引發的零件採購變化，例如電子子系統、磁性組件和專用感測器，如果定價策略不進行調整，可能會導致單位製造成本上升和利潤率下降。因此，採購團隊正在重新評估其供應商基礎，探索替代生產地點，並加速雙重採購以降低集中採購風險。

針對設備類型、底層技術、臨床和消費者應用、使用者環境、通路和人口統計群體進行高解析度細分分析。

穩健的細分分析揭示了產品創新和商業化在設備外形、底層技術、應用領域、終端用戶環境、分銷管道和年齡層等方面能夠帶來特別高回報的領域。從裝置類型來看，非侵入式神經刺激設備）、專注於認知評估和神經回饋的軟體套件，以及將感測器功能與使用者舒適度相結合的穿戴式裝置（例如帽子和頭帶）都蘊藏著不同的機會。能夠將硬體人體工學與清晰的軟體驅動效能指標結合的公司，可以加速臨床應用和消費者滲透。

美洲、歐洲、中東和非洲以及亞太地區的區域採用和商業化趨勢決定了差異化的打入市場策略和業務運作。

區域趨勢會影響部署時間、報銷途徑和供應鏈選擇，因此需要製定因地理而異的策略。在美洲，臨床網路和私人保險體系促進了實證醫療器材的早期應用，而充滿活力的創投生態系統則支援快速的原型到市場轉化週期。然而，經濟效益論證必須根據區域採購考量和報銷差異進行單獨調整。在歐洲、中東和非洲，監管協調工作和各國醫療保健模式的差異既帶來了挑戰也帶來了機遇，而集中採購舉措和區域卓越中心則影響著醫院和研究機構的部署。

競爭定位和能力映射揭示了競爭對手、軟體創新者和專業新參與企業如何塑造其差異化和夥伴關係模式。

腦健康設備生態系統內的競爭呈現出多種多樣的組織模式，既有擁有整合製造和監管專業知識的成熟醫療設備製造商，也有專注於演算法和使用者體驗的軟體公司。成熟製造商利用其臨床信譽和分銷網路推動產品在醫院和診所的應用，而軟體和穿戴式設備領域的新興參與企業則往往優先考慮以消費者為中心的人體工學設計和快速迭代周期，以直接滿足消費者的需求。

經營團隊が運用リスクを低減し、エビデンス創出を加速させ、責任ある形で脳健康製品を拡大するための実践的かつ段階的な提言

產業領導者應優先採取切實可行的措施，在保持戰略選擇權的同時，加速安全且擴充性的部署。首先，應實現採購和製造地的多元化，以降低關稅風險和供應中斷的影響。這包括建立雙重籌資策略，並評估關鍵零件的近岸外包。其次，應策略性地投資於與預期用途聲明和支付方要求相符的臨床證據項目，開發結合隨機評估和真實世界結果的混合研究設計，以滿足監管機構和採購方的需求。

我們採用透明的多方法研究途徑，結合專家訪談、技術設備評估和政策分析，提供檢驗且可操作的見解。

本分析整合了多種研究途徑的洞見，強調三角驗證和透明度。主要資料來源包括對臨床醫生、醫療設備工程師、採購專家和監管機構的結構化訪談，並輔以醫療設備架構和軟體堆疊的技術審查。政策和關稅評估是基於公開的監管文件、海關指南和貿易通告，建構了切合實際的營運場景和風險緩解策略。此調查方法優先考慮對資訊來源進行交叉檢驗，以減少對單一資訊來源的依賴，並突出一致的策略主題。

脳健康デバイス分野における長期的な成功を、エビデンス,運用上のレジリエンス,夥伴關係がどのように決定づけるかを明確化する、戦略的示唆の簡潔な統合

總而言之，腦健康設備產業正從孤立的創新轉向整合的醫療保健和健康生態系統，其成功取決於臨床證據、使用者體驗、供應鏈韌性和監管準備的綜合考量。感測和刺激技術的進步拓寬了介入措施的範圍，但要實現永續應用，需要將這些技術與可驗證的成果和清晰的營運路徑結合。關稅趨勢和細微的區域監管差異增加了複雜性，因此擁有多元化供應鏈和靈活商業化策略的企業更具優勢。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 腦健康設備市場：依設備類型分類

  • 非侵入性
  • 軟體
    • 認知功能評估
    • 神經回饋系統
  • 穿戴式裝置
    • 帽子
    • 頭巾

第9章 脳健康デバイス市場：技術別

  • 神經回饋
    • 基於腦電圖
    • fNIRS 基線
  • 經顱直流電刺激
    • 多通道
    • 單通道
  • 經顱磁刺激
    • 深部經顱磁刺激
    • 重複經顱磁刺激

第10章 腦健康設備市場：依年齡層別分類

  • 成人版
  • 對於老年人
  • 兒童

第11章 脳健康デバイス市場：用途別

  • 臨床
    • 神經病學
    • 精神病學
  • 消費者健康
  • 運動表現

第12章 腦健康設備市場：依最終用戶分類

  • 診所
  • 家用
  • 醫院
  • 研究中心

第13章 脳健康デバイス市場：流通チャネル別

  • 離線
  • 線上

第14章 脳健康デバイス市場：地域別

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 腦健康設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 腦健康設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國：腦健康設備市場

第18章 中國：腦健康設備市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Boston Scientific Corporation
  • InteraXon Inc.
  • LivaNova PLC
  • Medtronic plc
  • Neuroelectrics Barcelona SL
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • NeuroSky, Inc.
  • Nevro Corp.
  • Stryker Corporation
Product Code: MRR-1A1A064C05FE

The Brain Health Device Market was valued at USD 8.59 billion in 2025 and is projected to grow to USD 9.62 billion in 2026, with a CAGR of 12.22%, reaching USD 19.25 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 8.59 billion
Estimated Year [2026] USD 9.62 billion
Forecast Year [2032] USD 19.25 billion
CAGR (%) 12.22%

Introducing the evolving brain health device landscape where clinical rigor, consumer expectations, and technological convergence define strategic imperatives

The brain health device arena sits at the confluence of clinical neuroscience, consumer technology, and digital therapeutics, creating a distinct category that blends physiological sensing, neuromodulation, and software-driven cognitive assessment. Advances in noninvasive stimulation, refined neurofeedback systems, and increasingly sophisticated wearables have expanded both clinical pathways and everyday wellness choices. This introduction frames the device ecosystem not merely as discrete product lines but as a networked set of tools that generate medical, behavioral, and experiential value for patients, clinicians, athletes, and consumers experimenting with cognitive enhancement.

As stakeholders navigate this evolving space, they confront a layered regulatory environment, accelerating evidence standards, and heightened expectations around data governance and interoperability. Clinicians seek reproducible outcomes and integration with existing care workflows, while consumer channels demand simplicity, comfort, and clear benefit stories. Meanwhile, software platforms aim to convert continuous signal streams into actionable insights without compromising privacy. This combination of technical complexity and market fragmentation creates both friction and opportunity: organizations that can align robust clinical validation with scalable product design will unlock differentiated adoption pathways.

The remainder of this executive summary lays out the shifts, segmentation lenses, regional dynamics, competitive implications, and concrete next steps leaders can deploy to steward innovation responsibly and capture sustainable advantage in brain health device markets.

Transformative technological, regulatory, and behavioral shifts that are driving new clinical and commercial adoption pathways across brain health devices

The landscape for brain health devices is being reshaped by three convergent forces: rapid technological maturation, evolving regulatory expectations, and changing user behavior across clinical and consumer domains. On the technology front, improvements in sensor fidelity, signal processing, and closed-loop neuromodulation are expanding the range of clinically relevant endpoints while reducing user burden. These advances enable devices to move from adjunctive research tools toward integrated care enablers and consumer wellness products with clearer outcome pathways.

Regulatory ecosystems are responding to this progress by raising the bar for clinical evidence and post-market surveillance, prompting manufacturers to invest earlier in robust study designs and real-world performance monitoring. At the same time, reimbursement frameworks and clinical adoption pathways are becoming more closely tied to demonstrated functional impact rather than device attributes alone. Consumer expectations drive a parallel track: users expect privacy-preserving data practices, elegant product experiences, and clear value propositions for nonclinical use cases. These demands catalyze shifts in go-to-market strategies and partnership models between device makers, software vendors, and healthcare providers.

Taken together, these trends force strategic clarity: companies must balance incremental product innovation with systemic investments in evidence generation, regulatory readiness, and ecosystem partnerships if they intend to convert technical capability into lasting clinical and commercial traction.

Evaluating how United States tariff developments through 2025 create supply chain, pricing, and strategic shifts that materially affect device commercialization and sourcing

United States tariff actions through 2025 introduce a complex set of operational and strategic effects for brain health device companies that extend beyond immediate cost pressures. Tariff-induced changes to component sourcing, particularly for electronic subsystems, magnetic assemblies, and specialized sensors, can increase unit manufacturing costs and compress margins if pricing strategies remain unchanged. As a result, procurement teams are reassessing supplier footprints, exploring alternative manufacturing geographies, and accelerating dual-sourcing to reduce concentration risk.

The tariff environment also alters the calculus for vertical integration and regional manufacturing. Some firms are evaluating nearshoring or establishing regional assembly hubs to mitigate tariff exposure and shorten lead times for clinical trial deployments. This shift has implications for capital allocation and timing of product launches, and it often requires renegotiation of distribution agreements and recalibration of inventory strategies. On the demand side, higher landed costs can complicate pricing conversations with payers and hospital procurement departments, particularly where reimbursement is sensitive to device price points.

Beyond direct cost effects, tariffs influence strategic alliances: partnerships with local manufacturers, contract research organizations, and regional distributors become more valuable as they smooth compliance, logistics, and customs challenges. Companies that proactively model scenario-based supply chain impacts, document cost pass-through strategies, and communicate transparently with customers and regulators will be better positioned to sustain market access and preserve commercialization momentum in a tariff-volatile environment.

High-resolution segmentation insights across device types, enabling technologies, clinical and consumer applications, user settings, channels, and demographic cohorts

A robust segmentation lens clarifies where product innovation and commercialization will deliver disproportionate returns across device form factors, enabling technologies, application domains, end-user settings, distribution channels, and age cohorts. When viewed by device type, opportunities diverge between noninvasive hardware such as nerve stimulation devices, software suites focused on cognitive assessment and neurofeedback, and wearables like caps and headbands that blend sensing with user comfort. Companies that align hardware ergonomics with clear software-driven outcome measures can accelerate clinical acceptance and consumer uptake alike.

Technology segmentation reveals differentiation around neurofeedback modalities, transcranial direct current stimulation variants, and transcranial magnetic stimulation formats. Within neurofeedback, EEG-based and fNIRS-based systems offer distinct trade-offs between temporal resolution and spatial specificity, informing use in cognitive training versus targeted rehabilitation. Transcranial direct current stimulation choices between multi-channel and single-channel architectures affect personalization capabilities and regulatory pathways, while deep TMS and repetitive TMS represent varying intensity and clinic-centric deployment models across the magnetic stimulation spectrum.

Application segmentation separates clinical deployments in neurology and psychiatry from consumer wellness and sports performance use cases, each demanding tailored evidence, user experiences, and reimbursement approaches. End users span clinics, home-use patients, hospitals, and research centers, which require differentiated service models and support. Distribution channels bifurcate into offline and online strategies, influencing margins and brand positioning, while age groups-adult, geriatric, and pediatric-necessitate distinct safety, usability, and engagement design features. Synthesis across these segmentation axes guides product roadmaps and targeted go-to-market plays.

Regional adoption and commercialization dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine differentiated go-to-market and operational plays

Regional dynamics shape adoption rhythms, reimbursement pathways, and supply chain choices in ways that require geographically nuanced strategies. In the Americas, clinical networks and private-payer frameworks favor early adoption of evidence-backed devices, while robust venture ecosystems support rapid prototype-to-market cycles; however, regional procurement sensitivities and reimbursement variability demand tailored economic narratives. Across Europe, Middle East & Africa, regulatory harmonization efforts and diverse national healthcare models present both friction and opportunity, with centralized procurement initiatives and regional Centers of Excellence influencing adoption among hospitals and research institutions.

Asia-Pacific markets exhibit a mix of rapid consumer-level embrace of wearables and strategic government investments in healthcare digitization, producing both sizable pilot platforms and highly competitive local manufacturing ecosystems. These geographies differ in their tolerance for direct-to-consumer neuromodulation versus clinic-administered treatments, and local regulatory expectations can accelerate or delay market entry depending on device classification. Cross-region partnerships and targeted clinical collaborations often function as the most effective route to navigate these variations, enabling companies to adapt evidence packages and distribution models while leveraging regional strengths in manufacturing, clinical research, or consumer engagement.

Taken together, a regionally differentiated approach-sensitive to payer structures, regulatory nuance, and consumer behavior-yields more predictable adoption curves and maximizes return on localized commercialization investments.

Competitive positioning and capability mapping that reveal how incumbents, software innovators, and specialized entrants are shaping differentiation and partnership models

Competitive dynamics within the brain health device ecosystem reflect a spectrum of organizational archetypes, ranging from established medical-device incumbents with integrated manufacturing and regulatory expertise to software-first companies that specialize in algorithms and user experience. Incumbent manufacturers often leverage clinical credibility and distribution networks to drive hospital and clinic adoption, while software and wearable entrants frequently prioritize consumer-focused ergonomics and rapid iteration cycles to capture direct-to-consumer demand.

A growing number of venture-backed challengers and research spinouts focus on narrowing clinical niches where novel neuromodulation or sensing approaches can demonstrate clear functional benefits. These players commonly form partnerships with academic centers to accelerate evidence generation and with contract manufacturers to scale production efficiently. Meanwhile, alliances between device firms and digital health platforms are increasing, as vendors integrate longitudinal outcome tracking, remote monitoring, and telehealth-enabled clinical oversight into their offerings to support reimbursement and adherence.

Strategic differentiation increasingly hinges on the ability to generate high-quality clinical data, secure favorable regulatory determinations, and demonstrate real-world impact through deployable service models. Companies that combine technological novelty with operational excellence in manufacturing, distribution, and post-market evidence collection will define the competitive frontier in the coming years.

Actionable, sequenced recommendations for leaders to reduce operational risk, accelerate evidence generation, and scale brain health products responsibly

Industry leaders should prioritize a set of practical actions that accelerate safe, scalable adoption while preserving strategic optionality. First, diversify procurement and manufacturing footprints to reduce tariff and supply disruption exposure; this includes building dual sourcing strategies and assessing nearshoring for critical subassemblies. Second, invest deliberately in clinical evidence programs that align with intended use claims and payer requirements, deploying hybrid study designs that combine randomized evaluations with real-world outcomes to satisfy both regulators and purchasers.

Third, design products and platforms with interoperability and data portability in mind to ease integration with electronic health records and telehealth workflows. Fourth, create clear, age-appropriate user experiences and training materials that address adult, geriatric, and pediatric needs to drive adherence and clinical utility. Fifth, adopt privacy-first data governance and transparent consent frameworks that build trust with clinicians and consumers alike, while preparing for evolving regulatory scrutiny on AI and data-driven claims.

Finally, pursue targeted partnerships with clinical networks, sports performance organizations, and consumer distribution channels to validate use cases and scale deployment. By sequencing these actions-supply chain mitigation, evidence generation, integration readiness, user-centered design, data governance, and strategic partnerships-leaders can convert technical capability into reproducible clinical and commercial outcomes.

Transparent multi-method research approach combining expert interviews, technical device assessment, and policy analysis to deliver validated and actionable insights

This analysis synthesizes findings from a multi-method research approach that emphasizes triangulation and transparency. Primary inputs comprised structured interviews with clinicians, device engineers, procurement specialists, and regulators, supplemented by technical reviews of device architecture and software stacks. Policy and tariff assessments were generated from public regulatory filings, customs guidance, and trade notices to construct plausible operational scenarios and mitigation pathways. The methodology prioritized cross-validation across sources to reduce reliance on single-channel signals and to surface consistent strategic themes.

Secondary research examined peer-reviewed clinical literature, white papers, and conference proceedings to evaluate evidence standards and outcome measures pertinent to device claims. Device usability and ergonomics were assessed through product documentation and, where available, hands-on demonstrations and developer briefings. The analysis acknowledges limitations inherent in rapidly evolving regulatory decisions and in proprietary commercial agreements that are not publicly disclosed; therefore, recommendations emphasize adaptable strategies that remain robust across potential future states.

All conclusions were iteratively reviewed with subject-matter experts to ensure technical accuracy and practical relevance. Where uncertainty exists-particularly around tariff trajectories and national regulatory reforms-scenarios are framed to aid decision-makers in stress-testing strategic choices rather than to provide deterministic forecasts.

Concise synthesis of strategic implications that crystallizes how evidence, operational resilience, and partnerships determine long-term success in brain health devices

In summary, the brain health device sector is transitioning from isolated innovations to integrated care and wellness ecosystems where clinical evidence, user experience, supply resilience, and regulatory readiness jointly determine success. Technological improvements in sensing and stimulation expand the palette of interventions, but durable adoption depends on aligning those capabilities with demonstrable outcomes and clear operational pathways. Tariff dynamics and regional regulatory nuance add layers of complexity that favor organizations with diversified supply chains and flexible commercialization playbooks.

Segmentation analysis highlights where focused investments will pay off: pairing device form factors with the right technology modality and application domain clarifies regulatory demands and commercialization channels. Regionally differentiated strategies unlock adoption advantages by respecting payer structures and deployment norms. Competitive advantage accrues to firms that combine robust clinical programs with scalable manufacturing and thoughtful data governance, enabling them to bridge clinical and consumer markets without sacrificing credibility.

Ultimately, stakeholders who adopt a disciplined, evidence-led commercialization strategy-underpinned by supply chain resilience and partnership-driven market entry-will be best positioned to translate innovation into meaningful clinical and commercial outcomes across the brain health landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Brain Health Device Market, by Device Type

  • 8.1. Noninvasive
  • 8.2. Software
    • 8.2.1. Cognitive Assessment
    • 8.2.2. Neurofeedback System
  • 8.3. Wearable
    • 8.3.1. Cap
    • 8.3.2. Headband

9. Brain Health Device Market, by Technology

  • 9.1. Neurofeedback
    • 9.1.1. EEG Based
    • 9.1.2. fNIRS Based
  • 9.2. Transcranial Direct Current Stimulation
    • 9.2.1. Multi Channel
    • 9.2.2. Single Channel
  • 9.3. Transcranial Magnetic Stimulation
    • 9.3.1. Deep TMS
    • 9.3.2. Repetitive TMS

10. Brain Health Device Market, by Age Group

  • 10.1. Adult
  • 10.2. Geriatric
  • 10.3. Pediatric

11. Brain Health Device Market, by Application

  • 11.1. Clinical
    • 11.1.1. Neurology
    • 11.1.2. Psychiatry
  • 11.2. Consumer Wellness
  • 11.3. Sports Performance

12. Brain Health Device Market, by End User

  • 12.1. Clinics
  • 12.2. Home Use
  • 12.3. Hospitals
  • 12.4. Research Centers

13. Brain Health Device Market, by Distribution Channel

  • 13.1. Offline
  • 13.2. Online

14. Brain Health Device Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Brain Health Device Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Brain Health Device Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Brain Health Device Market

18. China Brain Health Device Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Abbott Laboratories
  • 19.7. Boston Scientific Corporation
  • 19.8. Boston Scientific Corporation
  • 19.9. InteraXon Inc.
  • 19.10. LivaNova PLC
  • 19.11. Medtronic plc
  • 19.12. Neuroelectrics Barcelona S.L.
  • 19.13. NeuroPace, Inc.
  • 19.14. NeuroSigma, Inc.
  • 19.15. NeuroSky, Inc.
  • 19.16. Nevro Corp.
  • 19.17. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BRAIN HEALTH DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BRAIN HEALTH DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA BRAIN HEALTH DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NONINVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NONINVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NONINVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY COGNITIVE ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY COGNITIVE ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY COGNITIVE ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CAP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CAP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CAP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY HEADBAND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY HEADBAND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY HEADBAND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY EEG BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY EEG BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY EEG BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY FNIRS BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY FNIRS BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY FNIRS BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY MULTI CHANNEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY MULTI CHANNEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY MULTI CHANNEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY SINGLE CHANNEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY SINGLE CHANNEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY SINGLE CHANNEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY DEEP TMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY DEEP TMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY DEEP TMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY REPETITIVE TMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY REPETITIVE TMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY REPETITIVE TMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY PSYCHIATRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY PSYCHIATRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY PSYCHIATRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CONSUMER WELLNESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CONSUMER WELLNESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CONSUMER WELLNESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY SPORTS PERFORMANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY SPORTS PERFORMANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY SPORTS PERFORMANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY HOME USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY HOME USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY HOME USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY RESEARCH CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY RESEARCH CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 226. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 227. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 228. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 229. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 230. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 231. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 232. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 234. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. GCC BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 263. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 265. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 266. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 268. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 269. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 270. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 271. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 272. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 273. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. G7 BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 275. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 276. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 278. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 279. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 280. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 281. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 282. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 283. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 284. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 285. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 286. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 287. NATO BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 288. GLOBAL BRAIN HEALTH DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 298. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 300. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED STATES BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 302. CHINA BRAIN HEALTH DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 303. CHINA BRAIN HEALTH DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. CHINA BRAIN HEALTH DEVICE MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 305. CHINA BRAIN HEALTH DEVICE MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 306. CHINA BRAIN HEALTH DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 307. CHINA BRAIN HEALTH DEVICE MARKET SIZE, BY NEUROFEEDBACK, 2018-2032 (USD MILLION)
  • TABLE 308. CHINA BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL DIRECT CURRENT STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 309. CHINA BRAIN HEALTH DEVICE MARKET SIZE, BY TRANSCRANIAL MAGNETIC STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 310. CHINA BRAIN HEALTH DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 311. CHINA BRAIN HEALTH DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 312. CHINA BRAIN HEALTH DEVICE MARKET SIZE, BY CLINICAL, 2018-2032 (USD MILLION)
  • TABLE 313. CHINA BRAIN HEALTH DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 314. CHINA BRAIN HEALTH DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)